Notable Labs, Ltd.

Market Cap

$96

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$0.00+$0.00 (+0.00%)

Jan 15, 2026

52W High $0.0252W Low $0.00

Company Details

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive medicines for patients with cancer. The company, through its proprietary Predictive Medicines Platform (PMP), bio-simulates a patient's cancer treatment...

Leadership

Scott Alan McPherson CFE, CPA, CVA

Chief Financial Officer

Joseph P. Wagner Ph.D.

Chief Scientific Officer

Kaile Zagger

Interim CEO & Chief Restructuring Officer

Glenn C. Michelson M.D.

Chief Medical Officer

IPO Date

—

Website

www.notablelabs.com

Key Metrics TTM

Revenue

$3.0K

- YoY

Net Income

-$19M

EPS (Diluted)

Free Cash Flow

-$7M

Revenue / Share

$0.00

Gross Margin

100.0%

Operating Margin

-590766.7%

Net Margin

-623066.7%

FCF Margin

-242866.7%

P/S

0.0x

P/E

Revenue & Profitability

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee